Quality of Life and Symptom Burden in Non-Small-Cell Lung Cancer Patients Receiving Second-Line Chemotherapy Compared with Immunotherapy

Quality of Life and Symptom Burden in Non-Small-Cell Lung Cancer Patients Receiving Second-Line Chemotherapy Compared with Immunotherapy

<i>Background and Objectives</i>: The burdened symptomatology accompanying advanced non-small-cell lung cancer (NSCLC) is associated with poor prognosis and lower quality of life (QoL). Although both chemotherapy and immunotherapy increase survival, they are still associated with reduced...

Full description

Saved in:
Bibliographic Details
Main Authors: Christos Stylianou, Ioannis Kalemikerakis, Theocharis Konstantinidis, Alkmena Kafazi, Nektarios Alevizopoulos, Stelios Parissopoulos, Ourania Govina
Format: Article
Language:English
Published: MDPI AG 2024-11-01
Series:Medicina
Subjects:
chemotherapy
immunotherapy
non-small-cell lung cancer
symptoms
quality of life
Online Access:https://www.mdpi.com/1648-9144/60/11/1845
Tags: Add Tag
No Tags, Be the first to tag this record!
Be the first to leave a comment!
You must be logged in first

Similar Items